A Phase II Study Of Rituximab-CHOP With Pegylated Liposomal Doxorubicin In Patients Older Than 60 Years Of Age With Untreated Aggressive B-Cell Non-Hodgkin's Lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Doxorubicin liposomal; Filgrastim; Pegfilgrastim; Prednisone; Rituximab; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 19 Oct 2020 Biomarkers information updated
- 29 Oct 2013 Planned end date changed from 1 May 2013 to 1 May 2015 as reported by ClinicalTrials.gov.
- 29 Oct 2013 Planned end date changed from 1 May 2013 to 1 May 2015 as reported by ClinicalTrials.gov.